Mumbai, Nov. 24 -- Dr Reddys Laboratories announced that the European Commission (EC) has granted marketing authorization for AVT03, a biosimilar of Prolia(R) (denosumab) and Xgeva(R) (denosumab).

Published by HT Digital Content Services with permission from Capital Market....